Back to search
FDAFDA · Food and drugs·Recall number Z-1489-2023

ANGIOGUARD RX / XP Emboli Capture Guidewire System, REF 501814REC

Published May 17, 2023 · Recall initiated: March 24, 2023

Summary

FDA records medical device Class I recall Z-1489-2023, published May 17, 2023 and initiated March 24, 2023. Recalling firm: Cordis US Corp; Status: Ongoing; Reported quantity: 40 units; Lot: UDI/DI 20705032054789; Lot Numbers: 35264223. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

There is a potential for separation of the ANGIOGUARD RX / XP delivery system and capture sheath which include but are not limited to situations of an intra-procedural delay, unplanned percutaneous or surgical intervention, or stroke; while a replacement device is prepared.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Cordis US Corp
Distributor
Worldwide distribution.
Lot
UDI/DI 20705032054789; Lot Numbers: 35264223
Risk classification
Class I
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was ANGIOGUARD RX / XP Emboli Capture Guidewire System, REF 501814REC recalled?

Yes. FDA published recall Z-1489-2023 on May 17, 2023. Reported hazard: There is a potential for separation of the ANGIOGUARD RX / XP delivery system and capture sheath which include but are not limited to situations of an intra-procedural delay, unplanned percutaneous or surgical intervention, or stroke; while a replacement device is prepared.

What should I do if I have this product?

Voluntary: Firm initiated · Letter